Pioglitazone restores the homocysteine‑impaired function of endothelial progenitor cells via the inhibition of the protein kinase C/NADPH oxidase pathway

Zhu,Junhui; Zhao,Yanbo; Yu,Lu; Wang,Meihui; Li,Qinfeng; Xu,Shengjie

doi:10.3892/mmr.2018.9154

Pioglitazone restores the homocysteine‑impaired function of endothelial progenitor cells via the inhibition of the protein kinase C/NADPH oxidase pathway

Authors:
- Junhui Zhu
- Yanbo Zhao
- Lu Yu
- Meihui Wang
- Qinfeng Li
- Shengjie Xu
View Affiliations

Affiliations: Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China
Published online on: June 11, 2018 https://doi.org/10.3892/mmr.2018.9154
Pages: 1637-1643
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Homocysteine (Hcy) has been shown to impair the migratory and adhesive activity of endothelial progenitor cells (EPCs). As a peroxisome proliferator‑activated receptor γ agonist, pioglitazone (PIO) has been predicted to regulate angiogenesis, and cell adhesion, migration and survival. The aim of the present study was to determine whether PIO could inhibit Hcy‑induced EPC dysfunctions such as impairments of cell migration and adhesion. EPC migration and adhesion were assayed using 8.0‑µm pore size Transwell membranes and fibronectin‑coated culture dishes, respectively. Hcy at a concentration of 200 µM was observed to markedly impair cell migration and adhesiveness, and PIO at a concentration of 10 µM attenuated the Hcy‑mediated inhibition of EPC migration and adhesion. The mechanism of these effects may be through the inhibition of protein kinase C (PKC) and reactive oxygen species production. The expression levels of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits, NADPH oxidase 2 (Nox2) and p67phox, were upregulated by Hcy, with a peak in levels following treatment with a concentration of 200 µM. PIO downregulated the expression levels of Nox2 and p67phox via the PKC signaling pathway. Furthermore, the mechanism of PIO associated with downregulating the p67phox and Nox2 subunits of NADPH oxidase was verified. Thus, PKC and NADPH oxidase may serve a major role in the protective effects of PIO in EPCs under conditions of high Hcy concentrations.

View Figures

View References

1	Abe Y, Ozaki Y, Kasuya J, Yamamoto K, Ando J, Sudo R, Ikeda M and Tanishita K: Endothelial progenitor cells promote directional three-dimensional endothelial network formation by secreting vascular endothelial growth factor. PLoS One. 8:e820852013. View Article : Google Scholar : PubMed/NCBI
2	Zhu JH, Chen JZ, Wang XX, Xie XD, Sun J and Zhang FR: Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol. 40:648–652. 2006. View Article : Google Scholar : PubMed/NCBI
3	Chen JZ, Zhu JH, Wang XX, Zhu JH, Xie XD, Sun J, Shang YP, Guo XG, Dai HM and Hu SJ: Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol. 36:233–239. 2004. View Article : Google Scholar : PubMed/NCBI
4	Bao XM, Wu CF and Lu GP: Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK. Atherosclerosis. 210:114–121. 2010. View Article : Google Scholar : PubMed/NCBI
5	Wang W, Vellaisamy K, Li G, Wu C, Ko CN, Leung CH and Ma DL: Development of a long-lived luminescence probe for visualizing β-galactosidase in ovarian carcinoma cells. Anal Chem. 89:11679–11684. 2017. View Article : Google Scholar : PubMed/NCBI
6	Ko CN, Wu C, Li G, Leung CH, Liu JB and Ma DL: A long-lived ferrocene-conjugated iridium(III) complex for sensitive turn-on luminescence detection of traces of DMSO in water and human serum. Anal Chim Acta. 984:193–201. 2017. View Article : Google Scholar : PubMed/NCBI
7	Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, D'Agostino RB Sr, Perez A, Provost JC and Haffner SM: Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: A randomized trial. JAMA. 296:2572–2581. 2006. View Article : Google Scholar : PubMed/NCBI
8	Spigoni V, Picconi A, Cito M, Ridolfi V, Bonomini S, Casali C, Zavaroni I, Gnudi L, Metra M and Dei Cas A: Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance. PLoS One. 7:e482832012. View Article : Google Scholar : PubMed/NCBI
9	Gensch C, Clever YP, Werner C, Hanhoun M, Böhm M and Laufs U: The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis. 192:67–74. 2007. View Article : Google Scholar : PubMed/NCBI
10	Imanishi T, Kobayashi K, Kuroi A, Ikejima H and Akasaka T: Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell. Hypertens Res. 31:757–765. 2008. View Article : Google Scholar : PubMed/NCBI
11	Jiang X, Yang F, Tan H, Liao D, Bryan RM Jr, Randhawa JK, Rumbaut RE, Durante W, Schafer AI, Yang X and Wang H: Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol. 25:2515–2521. 2005. View Article : Google Scholar : PubMed/NCBI
12	Siow YL, Au-Yeung KK and Woo CW OK: Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation. Biochem J. 398:73–82. 2006. View Article : Google Scholar : PubMed/NCBI
13	Xu S, Zhao Y, Jin C, Yu L, Ding F, Fu G and Zhu J: PKC/NADPH oxidase are involved in the protective effect of pioglitazone in high homocysteine-induced paracrine dyfunction in endothelial progenitor cells. Am J Transl Res. 9:1037–1048. 2017.PubMed/NCBI
14	Nelson J, Wu Y, Jiang X, Berretta R, Houser S, Choi E, Wang J, Huang J, Yang X and Wang H: Hyperhomocysteinemia suppresses bone marrow CD34+/VEGF receptor 2+ cells and inhibits progenitor cell mobilization and homing to injured vasculature-a role of β1-integrin in progenitor cell migration and adhesion. FASEB J. 29:3085–3099. 2015. View Article : Google Scholar : PubMed/NCBI
15	Bao XM, Wu CF and Lu GP: Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Acta Pharmacol Sin. 31:476–484. 2010. View Article : Google Scholar : PubMed/NCBI
16	Werner C, Gensch C, Pöss J, Haendeler J, Böhm M and Laufs U: Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis. Atherosclerosis. 216:23–34. 2011. View Article : Google Scholar : PubMed/NCBI
17	Alvarez-Maqueda M, El Bekay R, Monteseirín J, Alba G, Chacón P, Vega A, Santa María C, Tejedo JR, Martín-Nieto J, Bedoya FJ, et al: Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis. 172:229–238. 2004. View Article : Google Scholar : PubMed/NCBI
18	Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G and Koller A: Increased superoxide production in coronary arteries in hyperhomocysteinemia: Role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 23:418–424. 2003. View Article : Google Scholar : PubMed/NCBI
19	Sirker A, Zhang M and Shah AM: NADPH oxidases in cardiovascular disease: Insights from in vivo models and clinical studies. Basic Res Cardiol. 106:735–747. 2011. View Article : Google Scholar : PubMed/NCBI
20	Bedard K and Krause KH: The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev. 87:245–313. 2007. View Article : Google Scholar : PubMed/NCBI
21	Krenning G, van Luyn MJ and Harmsen MC: Endothelial progenitor cell-based neovascularization: Implications for therapy. Trends Mol Med. 15:180–189. 2009. View Article : Google Scholar : PubMed/NCBI